Veracyte Non Current Assets Total from 2010 to 2025

VCYT Stock  USD 25.25  1.66  7.04%   
Veracyte Non Current Assets Total yearly trend continues to be comparatively stable with very little volatility. Non Current Assets Total are likely to outpace its year average in 2025. Non Current Assets Total is the total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets. View All Fundamentals
 
Non Current Assets Total  
First Reported
2012-12-31
Previous Quarter
927.8 M
Current Value
932.3 M
Quarterly Volatility
410.8 M
 
Yuan Drop
 
Covid
Check Veracyte financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Veracyte's main balance sheet or income statement drivers, such as Depreciation And Amortization of 24.6 M, Interest Expense of 1.9 K or Selling General Administrative of 187.2 M, as well as many indicators such as Price To Sales Ratio of 6.45, Dividend Yield of 0.0 or PTB Ratio of 2.45. Veracyte financial statements analysis is a perfect complement when working with Veracyte Valuation or Volatility modules.
  
Build AI portfolio with Veracyte Stock
Check out the analysis of Veracyte Correlation against competitors.
For more information on how to buy Veracyte Stock please use our How to Invest in Veracyte guide.

Latest Veracyte's Non Current Assets Total Growth Pattern

Below is the plot of the Non Current Assets Total of Veracyte over the last few years. It is the total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets. Veracyte's Non Current Assets Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Veracyte's overall financial position and show how it may be relating to other accounts over time.
Non Current Assets Total10 Years Trend
Slightly volatile
   Non Current Assets Total   
       Timeline  

Veracyte Non Current Assets Total Regression Statistics

Arithmetic Mean309,793,666
Geometric Mean49,709,187
Coefficient Of Variation140.23
Mean Deviation388,052,415
Median27,407,000
Standard Deviation434,430,107
Sample Variance188729.5T
Range1B
R-Value0.83
Mean Square Error61584.9T
R-Squared0.70
Significance0.000059
Slope76,095,020
Total Sum of Squares2830942.8T

Veracyte Non Current Assets Total History

2025B
2024961.8 M
2023829.3 M
2022907.8 M
2021944.7 M
202081.5 M
201987.5 M

About Veracyte Financial Statements

Veracyte shareholders use historical fundamental indicators, such as Non Current Assets Total, to determine how well the company is positioned to perform in the future. Although Veracyte investors may analyze each financial statement separately, they are all interrelated. The changes in Veracyte's assets and liabilities, for example, are also reflected in the revenues and expenses on on Veracyte's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Non Current Assets Total961.8 MB

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Veracyte Stock Analysis

When running Veracyte's price analysis, check to measure Veracyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Veracyte is operating at the current time. Most of Veracyte's value examination focuses on studying past and present price action to predict the probability of Veracyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Veracyte's price. Additionally, you may evaluate how the addition of Veracyte to your portfolios can decrease your overall portfolio volatility.